Shandong Provincial Key Laboratory of Fluorine Chemistry and Chemical Materials, School of Chemistry and Chemical Engineering, University of Jinan, Jinan 250022, China.
Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
Bioorg Med Chem. 2021 Feb 1;31:115970. doi: 10.1016/j.bmc.2020.115970. Epub 2020 Dec 31.
The frequent and inappropriate use of antibiotics aggravate the variation and evolution of multidrug-resistant bacteria, posing a serious threat to public health. Nosiheptide (NOS) has excellent lethality against a variety of Gram-positive bacteria, however the physical and chemical drawbacks hamper its routine application in clinical practice. In this study, by using NOS as the starting material, a total of 15 NOS analogues (2a-4e) were semi-synthesized via its dehydroalanine residue reacting with monosubstituted anilines. In vitro antimicrobial susceptibilities of NOS and its analogues against two methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE) clinical isolates were determined by broth microdilution assay to determine the minimum inhibitory concentration (MIC). Antimicrobial susceptibility testing data shown that most of the NOS analogues had a better antibacterial effect than the parent compound, with compound 3c exhibiting the highest antibacterial activity against VRE (MIC = 0.0078 mg/L) and MRSA (MIC < 0.0039 mg/L). Molecular docking of synthetic compounds was also performed to verify the binding interactions of NOS analogues with the target. Our data indicated that compound 3c possesses stronger and more complex intermolecular force than other analogues, which is consistent with the results of the biological activity evaluation. Overall, this study identified a number of potential antibacterial NOS analogues that could act as potent therapeutic agents for multidrug-resistant bacterial infections.
抗生素的频繁和不适当使用加剧了多药耐药细菌的变异和进化，对公众健康构成了严重威胁。诺西肽 (NOS) 对多种革兰氏阳性菌具有极好的杀伤力，但理化缺陷阻碍了其在临床实践中的常规应用。在这项研究中，以 NOS 为起始原料，通过其脱水氨酸残基与单取代苯胺反应，共半合成了 15 种 NOS 类似物 (2a-4e)。采用肉汤微量稀释法测定 NOS 及其类似物对 2 株耐甲氧西林金黄色葡萄球菌 (MRSA) 和耐万古霉素粪肠球菌 (VRE) 临床分离株的体外药敏活性，以确定最小抑菌浓度 (MIC)。药敏试验数据表明，大多数 NOS 类似物的抗菌效果优于母体化合物，其中化合物 3c 对 VRE（MIC = 0.0078 mg/L）和 MRSA（MIC < 0.0039 mg/L）的抗菌活性最高。还对合成化合物进行了分子对接，以验证 NOS 类似物与靶标的结合相互作用。我们的数据表明，化合物 3c 与其他类似物相比具有更强和更复杂的分子间力，这与生物活性评价的结果一致。总体而言，这项研究确定了一些潜在的抗菌 NOS 类似物，它们可能成为治疗多药耐药细菌感染的有效药物。
